Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingbo Yang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Hao Chen

    Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Esophageal Cancer Institute, Sun Yat-Sen University Cancer Center, China

    1 shared publication
  • Qiangqiang Ouyang

    College of Artificial Intelligence and Low-Altitude Technology, South China Agricultural University, Guangzhou 510642, China

    1 shared publication
  • Runkun Han

    Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Guangdong Oesophageal Cancer Research Institute, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China

    1 shared publication
  • Shaoyi Wang

    Ultrasound Department, Guangdong Provincial Occupational Disease Prevention Hospital, Guangzhou 510300, China

    1 shared publication
  • Tianyou Chen

    College of Artificial Intelligence and Low-Altitude Technology, South China Agricultural University, Guangzhou 510642, China

    1 shared publication
  • Xinhua Xu

    Department of Clinical Laboratory, State Key Laboratory of Oncology in South China, Guangdong Oesophageal Cancer Research Institute, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China

    1 shared publication

Latest Publications

  • Open Access

    A Weighted Neural Network Model Based on Laboratory Tests for Identifying Lymph Node Metastases in Esophageal Squamous Cell Carcinomas

    by Qiangqiang Ouyang, Ziming Gao, Jingbo Yang, Shaoyi Wang, Zonglin Li, Yifan Zhang, Tianyou Chen, Xinhua Xu, Runkun Han, Hao Chen

    Lymph node metastasis (LNM) is a key prognostic factor in esophageal squamous cell carcinoma (ESCC), and accurate preoperative prediction remains challenging. Blood biomarkers provide a conventional, preoperative diagnostic technique that is cost-effective and free from radiation risks. So far, previous studies have been published on the precise diagnosis of lymph node metastases using conventional ultrasound or CT techniques. While there is a lack of research studies that address the diagnosis of LNM from blood biomarkers. In this work, we acquired a cohort of blood biomarkers of 1933 patients and designed a weighted neural network (WNN) model for the accurate prediction of LNM from blood biomarkers. The WNN model is designed with a neural network classifier trained on blood biomarkers labeled with pathological nodal (pN) stages of LNM. The experimental findings demonstrate that the WNN model achieved 83.1% accuracy and an AUC of 0.88 on the original, non-augmented test set for diagnosing LNM, while CT only achieved 50.4% accuracy (AUC 0.60) and ultrasound achieved 60.5% accuracy (AUC 0.67). Additionally, SHAP analysis reveals that three blood biomarkers—white blood cells (WBC#), monocytes (Mono#), and neutrophils (Neut#)—significantly impact the WNN model’s output. This WNN model shows promise as a research tool to diagnose LNM.